Next Big Innovation Lab
Develops customizable bioprinting platforms, including the Trivima series, for tissue engineering, drug testing, and organ-on-a-chip applications.
- CEO / Founder
- Alok Medikepura Anil
- Team Size
- 11-50
- Stage
- Commercial
- Total Funding
- $80K
- Latest Round
- Grant
- Key Investors
- Government of Karnataka, India’s Department of Biotechnology, Lockheed Martin, TATA Trusts, Merck Group, BIRAC, Merck Accelerator Program, Microsoft Startup Program
Technology & Products
Key Products
Trivima series bioprinters
Technological Advantage
Proprietary fusion of extrusion printing, materials science, and AI; secured two patents for bioprinting human tissue, providing a defensible technological moat in tissue engineering.
Differentiation
Value Proposition
Reduces R&D timelines and eliminates animal testing by providing AI-enabled, customizable bioprinting systems capable of producing complex 3D tissue constructs and corneal tissue.
How They Differentiate
Differentiates from European incumbents through Indian manufacturing cost-efficiency, deep AI integration for process optimization, and a specific focus on the clinical transition for organ fabrication.
Market & Competition
Target Customers
Researchers, clinicians, hospitals, and labs in tissue engineering, regenerative medicine, pharmaceuticals, and cosmetics R&D.
Industry Verticals
Healthcare; Life Sciences; Drug Discovery; Disease Research; Cosmetics
Competitors
RegenHU; Cellink
Growth & Milestones
Growth Metrics
Named a World Economic Forum Technology Pioneer in 2023; Secured funding from Merck's Accelerator program and the Government of Karnataka; Established a strategic partnership with HiMedia Laboratories for the global distribution of bioprinting products; Deployed Trivima bioprinting platforms in research institutions globally.
Major Milestones
Joined Bangalore Bioinnovation Centre incubation; Launched Trivima series bioprinters in India; Selected for Microsoft Startup Program; Named World Economic Forum Technology Pioneer; Established international project with Merck KGaA; Signed MoU with Karnataka government for R&D
Notable Customers
Moopen Medical College